All Viruses articles – Page 14
-
NewsResearchers solve mystery behind rare clotting after adenoviral vaccines or natural adenovirus infection
Scientists have uncovered why a small number of people developed dangerous blood clots after either receiving certain COVID‑19 vaccines or experiencing a natural adenovirus infection - the answer lies in an unexpected case of misdirected targeting by the immune system.
-
NewsVirus-based therapy boosts anti-cancer immune responses to brain cancer
A study has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can recruit immune cells to penetrate and persist deep within brain tumors.
-
NewsGenotype-specific response to 144-week entecavir therapy for HBeAg-positive chronic hepatitis B
HBV genotype B demonstrates superior histological responses to ETV therapy compared with genotype C, supporting the clinical value of HBV genotyping for personalized CHB management. These findings highlight the importance of considering viral genotype when evaluating treatment outcomes.
-
NewsLong COVID linked to Alzheimer’s disease mechanisms
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood markers of Alzheimer’s disease and greater levels of dementia, a new study finds.
-
NewsResearchers develop simple at-home tests for detecting cat and dog viruses
Researchers report improved lateral flow assays for at-home screening of cats and dogs. In tests on veterinary clinic samples, the assays demonstrated 100% sensitivity and reproducibility for both feline parvovirus and canine parvovirus.
-
NewsObesity linked to one in 10 infection deaths globally
Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new study. People with obesity face a 70% higher risk of hospitalisation or death from an infection than those of a healthy weight.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsScientists uncover link between influenza and heart disease
Researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.
-
NewsH5N1 causes die-off of Antarctic skuas
More than 50 skuas in Antarctica died from the high pathogenicity avian influenza virus H5N1 in the summers of 2023 and 2024, marking the first documented die-off of wildlife from the virus on the continent.
-
NewsNext generation genetics technology developed to counter the rise of antibiotic resistance
The new Pro-Active Genetics (Pro-AG) tool called pPro-MobV is a second-generation technology that uses an approach similar to gene drives to disable drug resistance in populations of bacteria.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
News
New vaccine platform promotes rare protective B cells
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
-
NewsNew study: Immune cells linked to Epstein-Barr virus may play a role in MS
Researchers have found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune response seen in MS.
-
NewsStudy reveals dual forces driving SARS-CoV-2 evolution: Immune pressure and viral fitness
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
-
NewsBreakthrough in human norovirus research: Researchers overcome major obstacle to grow and study the virus
Researchers have overcome a major obstacle that limited their ability to continuously grow human norovirus. They identified factors that restrict viral replication and developed a way to overcome them to optimize long-term viral cultivation.
-
NewsTesting menstrual blood for HPV could be “robust alternative” to cervical screening
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study. The researchers say using menstrual blood for HPV testing is convenient and non-invasive.
-
NewsNew study reveals a minimalist bacterial defense that disrupts viral assembly
Researchers describe how a single protein named Rip1 recognizes bacteriophages, the viruses that infect bacteria, and cause infected bacteria to die prematurely, thereby ending the chain of transmission.
-
NewsPreviously unknown viruses discovered in groundwater
Researchers have created a comprehensive picture of viral diversity and function in a groundwater system. They identified over 257,000 viral operational taxonomic units, i.e. viruses at species level, 99 % of which were previously unknown.
-
NewsScientists demonstrate first-ever single-shot HIV vaccine neutralization success
Scientists have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates.
-
NewsWhy aren’t more older adults getting flu or COVID-19 shots?
This winter’s brutal flu season isn’t over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the US survey reveals key reasons why.